Melatonin Vitabalans

Melatonin, the active ingredient in Melatonin Vitabalans, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps regulate the circadian rhythm and is used to promote sleep onset in individuals with insomnia, jet lag or other sleep‑onset difficulties.

GNH USA supplies Melatonin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide across Europe, Asia and the Americas. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Melatonin acts on the melatonin receptor pathway to address sleep‑related disorders.

- Insomnia: improves sleep initiation and reduces nighttime awakenings. - Sleep onset difficulties: shortens the time required to fall asleep. - Jet lag: helps realign the internal clock after rapid time‑zone travel.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Dizziness: transient sensation of light‑headedness. - Nausea: occasional stomach upset. - Daytime sleepiness: residual drowsiness if taken too late. - Vivid dreams: unusual or intense dreaming experiences.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe depression or mood changes: rare but may require medical attention.

When considering melatonin therapy, several safety measures are recommended.

- Assess medical history: evaluate for underlying sleep disorders or endocrine conditions. - Avoid operating machinery: potential residual drowsiness may impair alertness. - Consult physician if pregnant or breastfeeding: safety data are limited. - Do not combine with other sedatives without medical advice: risk of additive CNS depression. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Melatonin may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Warfarin: melatonin can increase anticoagulant effect, raising bleeding risk. - CNS depressants (e.g., benzodiazepines, barbiturates): additive sedation may occur.

Moderate Interactions (Monitor Closely):\n- Caffeine: may diminish melatonin's sleep‑promoting effect. - Antidepressants (SSRIs, SNRIs): can alter melatonin metabolism. - Oral contraceptives: may raise plasma melatonin concentrations.